Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JAMA
Finance
Oncology biosimilars brought hospitals increased margins: study
A JAMA study outlines biosimilar acquisition costs that fell faster than reimbursement decreases as well as an accompanying jump in utilization.
Dave Muoio
Mar 16, 2026 5:30pm
Study: Forced MA disenrollments rise amid payer plan exits
Feb 20, 2026 4:20pm
H-1B visa fee spike could hit rural, poor community docs hardest
Oct 30, 2025 4:55pm
Fierce Pharma
Ousted ACIP members fire back at RFK Jr.'s vaccine meddling
Jun 17, 2025 2:32pm
JAMA, OpenEvidence strike multi-year content agreement
Jun 5, 2025 4:30pm
Payer Roundup—SCAN Group acquires myPlace; Medicaid cuts impacts
May 29, 2025 3:00pm
